It is well known that IFNγ binding to its receptors on cancer cells can triggers the IFNγ/JAK/STAT pathway that can result in increased PD‐L1 expression as a defense mechanism against T cell attacks in most tumors [48]. This evidence concerns the gene SOAT1 and cancer.